Is Fate Therapeutics, Inc. (FATE) a Buy, Sell, or Hold?
Fate Therapeutics, Inc.
NASDAQ:FATE
$2.99 USD
-$0.03 (-0.99%)
- Volume
- 1.88M
- Average Volume
- 4.09M
- Market Capitalization
- $348.51M
- P/E Ratio
- -2.74
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $3.23
- Year Low
- $0.91
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.85
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-45.6% DOWNSIDE
$5.50 Price Target
UPSIDE/DOWNSIDE HIGH
-57.3% DOWNSIDE
$7.00 Price Target High
UPSIDE/DOWNSIDE LOW
-25.3% DOWNSIDE
$4.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Debjit Chattopadhyay | $7 | $1.98 | 2026-06-08 06:58 AM | 253.5% |
| BMO Capital | Etzer Darout | $5 | $3.37 | 2024-11-13 08:53 AM | 48.4% |
| Stifel Nicolaus | Benjamin Burnett | $5 | $3.27 | 2024-08-14 04:37 AM | 52.9% |
| Piper Sandler | Edward Tenthoff | $6 | $3.605 | 2024-06-16 11:50 PM | 66.4% |
| H.C. Wainwright | Debjit Chattopadhyay | $5 | $4.24 | 2024-05-16 02:44 AM | 17.9% |
| Piper Sandler | Edward Tenthoff | $4 | $3.88 | 2024-05-10 04:14 AM | 3.1% |
| BMO Capital | Etzer Darout | $6 | $3.865 | 2024-05-10 03:55 AM | 55.2% |
| Canaccord Genuity | Bill Maughan | $9 | $3.9 | 2024-05-10 03:28 AM | 130.8% |